Vimarsana
Biggest News Aggregation in the World

Phase 2a Study News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Phase 2a Study. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Phase 2a Study Today - Breaking & Trending Today

VDA-1102 Demonstrates Favorable Activity in Mycosis Fungoides - Vimarsana News

VDA-1102 Demonstrates Favorable Activity in Mycosis Fungoides

VDA-1102 led to an objective response rate of 56% in patients with mycosis fungoides, according to findings from an interim analysis of a phase 2a study.

Structure Therapeutics Initiates Phase 2a Study of Oral GLP-1 agonist GSBR-1290 for the Treatment of Type 2 Diabetes and Obesity - Vimarsana News

Structure Therapeutics Initiates Phase 2a Study of Oral GLP-1 agonist GSBR-1290 for the Treatment of Type 2 Diabetes and Obesity

Structure Therapeutics Initiates Phase 2a Study of Oral GLP-1 agonist GSBR-1290 for the Treatment of Type 2 Diabetes and Obesity.